Syngen Biotech Co.,Ltd. (TPEX:8279)
Taiwan · Delayed Price · Currency is TWD 79.70
+0.50 (0.63%)
Oct 20, 2026, 1:30 PM CST
Syngen Biotech Market Cap
Syngen Biotech has a market cap or net worth of 2.16 billion as of October 20, 2026. It is the 28,203rd most valuable company in the world and the 1,614th biggest in Taiwan. Its market cap has decreased by 37.98% in one year.
Market Cap
2.16B
Enterprise Value
2.12B
Revenue
2.05B
Global Rank
Country Rank
#1,614 Taiwan
PE Ratio
9.57
ChartMarket Cap Chart
Since November 2, 2004, Syngen Biotech's market cap has increased from 372.00M to 2.16B, an increase of 480.63%. That is a compound annual growth rate of 8.33%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 20, 2026 | 2.16B | -31.29% |
| Dec 31, 2025 | 3.14B | -8.66% |
| Dec 30, 2024 | 3.44B | -16.45% |
| Dec 29, 2023 | 4.12B | -6.17% |
| Dec 30, 2022 | 4.39B | 43.36% |
| Dec 30, 2021 | 3.06B | 4.63% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Chunghwa Chemical Synthesis & Biotech | 2.64B |
| GlycoNex Incorporation | 2.44B |
| HeXun Biosciences | 2.32B |
| Gwo Xi Stem Cell Applied Technology Co. , | 2.22B |
| Taiwan Bio Therapeutics | 2.21B |
| G&E Herbal Biotechnology | 1.88B |
| Anti-Microbial Savior BioteQ | 1.84B |
| U-Neuron Biomedical | 1.78B |